Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pharmacognosy Department, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
Metab Brain Dis. 2021 Jun;36(5):737-749. doi: 10.1007/s11011-021-00697-5. Epub 2021 Feb 19.
Amyotrophic lateral sclerosis (ALS) is a deadly motor neuron disease (MND) and the most frequent MND in adults. ALS is recognized by degenerative alterations in both upper and lower motor neurons. This disorder is classified to familial and sporadic classes. Disease-causing mutations in SOD1, C9ORF72, FUS, and TARDBP have been recognized in familial ALS cases. However, in spite of conduction of several genetic association studies, heritable genetic risk elements in sporadic have not been identified completely. Several miRNAs have been dysregulated in the serum samples or brain tissues of ALS patients. Moreover, a number of miRNAs have been suggested as putative biomarkers for sporadic ALS. In the current manuscript, we review of miRNAs in the development of ALS.
肌萎缩侧索硬化症(ALS)是一种致命的运动神经元疾病(MND),也是成年人中最常见的 MND。ALS 的特征是上下运动神经元均出现退行性改变。这种疾病分为家族性和散发性两类。在家族性 ALS 病例中已发现 SOD1、C9ORF72、FUS 和 TARDBP 的致病突变。然而,尽管进行了多项遗传关联研究,但散发性疾病的遗传风险因素尚未完全确定。在 ALS 患者的血清样本或脑组织中,已有多种 miRNA 失调。此外,有许多 miRNA 被认为是散发性 ALS 的潜在生物标志物。在本手稿中,我们综述了 miRNA 在 ALS 发病机制中的作用。